Melemedjian, O. K., Asiedu, M. N., Tillu, D. V., Sanoja, R., Yan, J., Lark, A., . . . Price, T. J. (2011). Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. BioMed Central.
Styl ChicagoMelemedjian, Ohannes K., et al. Targeting Adenosine Monophosphate-activated Protein Kinase (AMPK) in Preclinical Models Reveals a Potential Mechanism for the Treatment of Neuropathic Pain. BioMed Central, 2011.
Citace podle MLAMelemedjian, Ohannes K., et al. Targeting Adenosine Monophosphate-activated Protein Kinase (AMPK) in Preclinical Models Reveals a Potential Mechanism for the Treatment of Neuropathic Pain. BioMed Central, 2011.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..